Background: Cardiac rupture, an uncommon yet catastrophic complication after acute myocardial infarction (AMI), has been studied primarily in the prethrombolytic and thrombolytic therapy eras but not in the direct percutaneous coronary intervention (d-PCI) reperfusion therapy era. The aim of this study was to delineate the incidence, potential risks, timing of occurrence, clinical features, and outcomes of cardiac rupture complicating AMI after d-PCI. 
R
upture of the myocardium after acute myocardial infarction (AMI) may involve the free wall of the left ventricle (LV), the interventricular septum, or the papillary muscles. [1] [2] [3] While LV free wall rupture and ventricular septal defect (VSD) are uncommon mechanical complications after AMI, they carry an extremely high mortality rate. [1] [2] [3] [4] The incidence, 2,4 -6 timing of occurrence, 7, 8 prognostic factors, 2 and clinical features 9, 10 and outcomes [1] [2] [3] [4] 11, 12 of AMI complicated by VSD and LV free wall rupture in both the prethrombolytic and thrombolytic therapy eras have been debated extensive. However, there are no available data with regard to the incidence, clinical features, and outcomes of these complications in patients with AMI undergoing direct percutaneous coronary intervention (d-PCI). Furthermore, previous studies 11, 12 have demonstrated that although thrombolytic therapy can reduce the incidence of cardiac rupture, this therapeutic management for patients with AMI also may accelerate early cardiac rupture. 2, 12 Whether this paradoxical effect of thrombolytic therapy also occurs in the present d-PCI reperfusion era remains unknown. Therefore, the aim of this study was to investigate the incidence, associated potential risk factors, timing of occurrence, and clinical outcomes of this complication in patients with AMI who have receiving d-PCI therapy, and the impact of d-PCI on and the importance of reperfusion time in this complication.
Materials and Methods

Patient Population
In our hospital, there were only a small number of patients with AMI who either refused d-PCI or were treated with lytic therapy. Most of the patients with AMI underwent d-PCI after informed consent was obtained. For the purpose of the study, all patients who underwent d-PCI were prospectively identified and entered into a computerized database. Between May 1993 and July 2002, d-PCI was performed in 1,250 patients of any age who had presented with AMI of Ͻ 12 h duration (or had experienced cardiogenic shock within 18 h) in our hospital. Of these 1,250 patients, 12 (0.96%) had cardiac rupture (including 3 patients with VSD and 9 patients with LV free wall rapture) that had occurred after receiving d-PCI. These 12 patients constituted our study population (group 1). The remaining 1,238 patients served as the control group (group 2).
Procedure and Protocol
The procedure and protocol have been described previously in detail. 13, 14 Before stents were available in our country, primary balloon angioplasty was performed in these patients, however, after stents were available in our country, stent implantation was strongly encouraged unless the infarct-related artery (IRA) had heavy calcification, a reference lumen diameter of Ͻ 2.5 mm, or a stent-like formation on the treatment site after coronary angioplasty. Left ventriculograms, which were immediately performed after angioplasty, were recorded for 30°right anterior oblique and 60°left anterior oblique views. Echocardiography was routinely performed in each patient either before or after d-PCI.
Platelet glycoprotein IIb/IIIa receptor antagonists have been available in our country since August 2000. In our hospital, all patients with AMIs are considered eligible for therapy with glycoprotein IIb/IIIa on presentation in the emergency department after informed consent is obtained, unless there are contraindications. As a result of our government medical insurance policy, only 8 patients (including 1 patient with LV free wall rupture) received abciximab therapy (a loading dose of 0.25 mg/kg body weight, followed by a maintenance infusion of 0.1 mg/min for 18 to 24 h), and 300 patients (including 2 patients with LV free wall rupture) received tirofiban therapy (a loading dose of 20 g/kg body weight, followed by a maintenance infusion of 0.15 g/min for 18 to 24 h). Continuous heparin infusion for a further 24 to 48 h was administered only to patients who received balloon angioplasty. Patients were treated with ticlopidine for 2 weeks if stenting was performed. Aspirin (100 mg po once a day) was administered to each patient indefinitely. All other medications, including nitrates, beta-blockers, diuretics, and angiotensin-converting enzyme inhibitors were used as needed in both groups.
Definitions
AMI was defined as the following: (1) typical chest pain lasting for Ͼ 30 min with ST-segment elevation of Ͼ 1 mm in two consecutive precordial or inferior leads and (2) typical chest pain lasting for Ͼ 30 min with a new onset of complete left bundle branch block. Procedural success was defined as a reduction in residual stenosis of Ͻ 50% by balloon angioplasty or successful stent deployment at the desired position with a residual stenosis of Ͻ 20% followed by Thrombolysis in Myocardial Infarction (TIMI) 15 grade 3 flow in the IRA. Body mass index (BMI) was defined as the weight (in kilograms) divided by the square of the height (in meters). VSD was first suspected by physical examination and subsequently was confirmed by echocardiography, a significant step-up in oxygen saturation between the right atrium and the pulmonary artery using a Swan-Ganz catheter, and operative findings. LV free wall rupture was suspected by a patient's sudden hemodynamic collapse associated with the patient's loss of consciousness and electromechanical dissociation without ECG evidence of malignant ventricular tachyarrhythmias. A diagnosis subsequently was made by echocardiographic findings of a new accumulated pericardial effusion and further was confirmed by pericardiocentesis via an apical approach method.
Data Collection
Detailed in-hospital and follow-up data including age, sex, coronary risk factors, Killip score on hospital admission, reperfusion time, pre-TIMI and post-TIMI flow grades, angiographic results, number of diseased vessels and coronary aneurysms, and number of in-hospital adverse events were obtained. These data were collected prospectively and were entered into a computerized database.
Statistical Analysis
Data were expressed as the mean Ϯ SD. Continuous variables were compared using the Wilcoxon rank sum test. Categoric variables were compared using the 2 test or Fischer exact test. Stepwise logistic regression analysis was used to determine the independent determinants of cardiac ruptures after d-PCI. Statistical analysis was performed using a statistical software package (SAS for Windows, version 6.12; SAS Institute; Cary, NC). A probability value of Ͻ 0.05 was considered to be statistically significant.
Results
Baseline Clinical Characteristics of the Patients
Relevant patient baseline characteristics are summarized in Tables 1. There were no significant differences in terms of the presence of diabetes mellitus or hypercholesterolemia, previous myocardial infarction, infarction locations, and the incidences of cardiogenic or noncardiogenic shock between patients with cardiac rupture and those without. However, patients with cardiac rupture had significantly higher incidences of hypertension and current smoking than did patients without this complication. Furthermore, patients with cardiac rupture were significantly older and thinner than were patients without this complication. By univariate logistic regression analysis, old age was significantly related to increased incidence of cardiac rupture (odds ratio, 1.11; 95% confidence interval, 1.04 to 1.18; p ϭ 0.0007). Moreover, the incidence of female gender was significantly higher in patients with cardiac rupture than in patients without it. In this study, female patients were significantly older than male patients (67.1 Ϯ 11.7 vs 60.8 Ϯ 11.9, respectively; p ϭ 0.0001). In addition, in the 12 patients with cardiac rupture, female patients were also older than male patients, although the difference did not reach statistical significance as a result of a type-2 error (75.1 Ϯ 7.7 vs 70.5 Ϯ 3.5, respectively; p ϭ 0.286).
Timing of Occurrence, Clinical Presentation, and Outcomes of Cardiac Rupture
Twelve of the 1,250 patients (0.96%) had cardiac rupture, including 3 with VSD and 9 with LV free wall rupture. However, neither pseudoaneurysm nor incomplete rupture of the LV free wall was found in these patients. Cardiac rupture developed after d-PCI in a mean time of 52.3 Ϯ 36.2 h (range, 4.8 h to 5 days). Clinical symptoms and signs in patients with VSD mostly showed an insidious presentation, and progressive dyspnea, worsening congestive heart failure, and pansystolic heart murmur during physical examination were the usual initial presentations. In contrast, patients with LV free wall rupture always presented with precipitous and unanticipated hemodynamic collapse. ECG monitoring showed sinus tachycardia, sinus bradycardia, junctional escape rhythm, or standstill without evidence of ventricular tachycardia/fibrillation. Echocardiograms showed pericardial effusion (Fig 1) . Pericardiocentesis was performed in five patients and showed clotted blood in all five. Cardiopulmonary resuscitation was uniformly unsuccessful in patients with LV free wall rupture, and all patients died as a result of this complication within minutes after its onset. An operation was performed in the three patients who had acquired VSD. One patient died in the hospital due to multiorgan failure, and the other two patients were discharged from the hospital uneventfully and have survived to the present.
Angiographic Findings, Angioplasty Results, Reperfusion Time, and 30-Day Mortality Rate of Patients
Relevant angiographic results, the time to reperfusion, and clinical outcome are summarized in Table 2 . There were no significant differences in terms of IRA, number of vessels affected by the disease, intercoronary collaterals, pre-TIMI and post-TIMI flow grades, or methods of reperfusion between patients with and without cardiac rupture. However, the incidence of a totally occluded left anterior descending artery (Fig 2) was significantly higher in patients with cardiac rupture than in patients without it (100% [9 of 9 patients] vs 66.4% [463 of 697 patients]; p ϭ 0.033). Furthermore, the mean time to reperfusion was significantly longer, and the mortality rate was significantly higher in patients with cardiac rupture than in patients without it.
Independent Predictors of Cardiac Rupture
Independent determinants of cardiac rupture are summarized in Table 3 . Multiple stepwise logistic regression analysis demonstrated that only old age, female gender, a lower BMI, and a longer time to reperfusion were significant independent predictors of cardiac rupture.
Discussion
Incidence of Cardiac Rupture in the d-PCI Reperfusion Era
In the present study, we found that the overall incidence of cardiac rupture was 0.96%, including 0.24% for VSD and 0.72% for LV free wall rupture. To the best of our knowledge, this is the first study to investigate the incidence, timing of occurrence, clinical features, and outcomes, as well as the predictors of myocardial rupture in patients with AMI undergoing d-PCI. The incidence of cardiac rupture was previously reported to be 4% in the prethrombolytic therapy era 5, 6 and Ͻ 1.0% in the thrombolytic therapy era. 2, 12 In addition, the incidence of LV free wall rupture was reported to be 8 to 10 times more frequent than that of VSD and the rupture of the papillary muscle. 16 Our findings are consistent with those of previous thrombolytic reperfusion studies 2,7,12 and further confirm the concept that early successful reperfusion either by thrombolysis or d-PCI may reduce the incidence of cardiac rupture after AMI.
Timing and Possible Mechanisms of Cardiac Rupture in the d-PCI Reperfusion Era
It has been stated 7,8 that the peak incidence of cardiac rupture occurs 5 to 7 days after infarction in the prethrombolytic therapy era. To the contrary, most cardiac ruptures that are associated with early thrombolytic therapy occur within 24 h after treatment. 2, 12, 16 These large clinical trials 2, 12, 16 also have demonstrated that although the frequency of cardiac rupture decreases, early thrombolytic therapy (ie, within 6 h) paradoxically accelerates the timing of this complication, and late thrombolytic therapy has been found to increase the risk of cardiac rupture. 11 Several possible mechanisms, including extension of myocardial hemorrhage weakening and dissection of the necrotizing zone, 12, 16 diminishing of the myocardial collagen content, 17 and digestion of collagen by collagenases 18, 19 and plasmin, 20 have been suggested.
In the present study, several important observations were made. First, the timing of cardiac rupture in our patients varied (range, 4.8 h to 5 days) with a mean time of 52.3 h. The mean time of occurrence of this complication in our patients was earlier than that in the prethrombolytic therapy era 7, 8 but was later than that in the thrombolytic therapy era, 2, 16 which suggests that reperfusion therapy by d-PCI does not accelerate the timing of cardiac rupture, as occurred with thrombolytic therapy. 2, 12, 16 Second, our patients with cardiac rupture had significantly longer time to reperfusion than did those without cardiac rupture. This finding suggests that the risk of cardiac rupture after AMI is related directly to the timing of reperfusion. Third, angiographic findings demonstrated that the incidence of a totally occluded left anterior descending artery was significantly higher in patients with cardiac rupture than in patients without it. This finding suggests that a transmural myocardial infarction is more likely to occur in these patients.
Relationships Among Age, Gender, BMI, and Cardiac Rupture
Advanced age has been found to be an increased risk factor for adverse outcomes after AMI. 21 The risks increased proportionally with advancing age, and primary angioplasty did not alter the relationship between adverse outcomes after AMI and being aged. 21 The contributing factors to this relationship included the presence of additional comorbid conditions, more advanced multivessel disease, and a longer time between the onset of symptoms and presentation for evaluation and treatment. [21] [22] [23] In the present study, old age was an independent predictor of cardiac rupture. Our finding confirmed the strong relationship between advanced age and increased adverse outcomes in the clinical setting of AMI.
Morbidity and mortality after AMI have been reported to be higher in women than in men. 24 In the present study, we also found that female gender was another independent predictor of cardiac rupture. In the present study, it is interesting to note that women constituted only 16.2% of our patient population. However, it is surprising that Ͼ 66% of patients with cardiac rupture were women. We remain uncertain why women are more likely to experience cardiac rupture after AMI. However, this may be due to older age in female patients and to other fundamental differences in the biology and pathophysiology of AMI between men and women. 24 In patients with coronary artery disease who are undergoing PCI, lean patients recently have been reported 25 to be at increased risk for in-hospital complications and cardiac death. However, the mechanism by which lean patients have an excess risk for these complications remains unclear. 25 In the present study, we also found that patients with cardiac rupture had significantly lower BMI values than those without this complication. Furthermore, multiple stepwise logistic regression analysis demonstrated that BMI was an independent predictor of cardiac rupture. This may reflex a synergic effect of being female and lean body weight on the predilection of cardiac rupture after AMI.
Formidable Challenges for Management of Cardiac Rupture
It is estimated that 8 to 17% of all fatal myocardial infarctions are the result of myocardial rupture. 26 Despite improvements in medical therapy and in percutaneous and surgical techniques, mortality from this complication remains extremely high. 2 These patients usually die immediately, even before a diagnosis can be confirmed. 4 In the present study, we found that the mortality rate caused by cardiac rupture was 8.9% (10 of 112 patients) of all fatal myocardial infarctions in our patient population. Our finding is consistent with previous observations. 12, 26 The overall mortality rate was very high (83.3%) in patients with cardiac rupture. It was disappointing that all of our patients with LV free wall rupture died despite heroic therapeutic bedside management. The primary obstacle in preventing death from LV free wall rupture is the extremely limited time in which surgery can be initiated, as the occurrence of LV free wall rupture is sudden and unanticipated without a constellation of signs or symptoms to indicate impending rupture in these patients, and it is followed by rapid hemodynamic deterioration.
There are several limitations to this study. First, the number of patients with cardiac rupture in this study was small, therefore, our results should be viewed as preliminary and need to await confirmation by larger clinical trials. Second, cardiac rupture, pseudoaneurysm, or incomplete rupture could easily be missed since premortem echocardiograms were often unavailable and cultural factors prevent postmortem examination. Therefore, the incidences of these complications could have been underestimated in our study. Third, as the number of patients with cardiac rupture was small in this study, the lack of significant differences in the incidences of previous myocardial infarction, anterior wall infarction, preinfarction angina, presence of collateral circulation, pre-TIMI flow, and method of reperfusion between patients with cardiac rupture and without could have been due to a type-2 error.
In conclusion, advanced age, female gender, a lower BMI, and longer time to reperfusion were significant independent predictors of cardiac rupture after AMI, and d-PCI had a favorable impact on reducing the incidence of cardiac rupture. Early successful d-PCI was the most significant independent determinant for preventing this catastrophic complication after AMI.
